The National Alliance of Advocates
for Buprenorphine Treatment
Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological
and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2
NAABT Privacy Policy
Your privacy is of great concern to us. We understand and respect your need for privacy when dealing with health issues, particularly addiction treatment. NAABT, Inc. will not collect any identifiable information about you (name, address, telephone number, or e-mail address) unless you voluntarily provide it to us. Any personal information you do submit to us will not be shared with any third party and will only be used as defined on the information submission page. For example, if you submit your identifiable information in order to receive our resource kit, that information will only be used to fill that order. Your information will not be published or stored on our website.
You are not required to give us any personal information in order to use the website. The only time you are asked for your personal information is in the event you ask us to mail you something and a mailing address is required. You may download and use the site anonymously and confidentially.
NAABT.org uses Javascript and Cookies to provide certain features to its users. In order to ensure the tools we've created to help you with receiving treatment work properly you need to have Javascript and Cookies enabled. Cookies place small bits of information on your hard drive, like username, password, and zip code. This information is also not shared with anyone and this feature can be turned off, in your browser’s security settings, however if disabled, parts of the site will no longer function.
See: Privacy policy, specifically for the Patient Physician Matching System
- U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
- Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.